Page 2 - Hetero Group

India's coronavirus drug market set for price war as firms ready launches

Sources say Cipla-BDR's favipiravir will be at least 30 per cent cheaper than Glenmark's price of Rs 103 per tablet. Cipla did not confirm.

A pricing war? Cipla pips Hetero, fixes remdesivir under Rs 5,000

A senior government official said it is in wait-and-watch mode and has not decided to take any suo motu action on the pricing of the drug

Hetero to deliver first set of 20,000 vials of Remdesivir as DCGI approves

One set would be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra

Coronavirus updates: Delhi second most-affected state; drug for patients

Donald Trump may announce foreign workers' visa restrictions today, protect Americans struggling with a job market devastated by the coronavirus pandemic

Hetero to launch remdesivir at Rs 5,000-6,000/dose, Cipla to follow suit

Industry sources estimate that at least 10,000 patients need the drug urgently in the areas with high case load

One in every 22 active Covid cases globally is in India; vaccine update

Of the 3,711,526 active cases around the world as of Sunday morning, 169,451 (4.57%) are in India

Hetero to launch Covid drug Remdesivir under brand name Covifor in India

Covifor (Remdesivir) will be available in 100 mg vial (Injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner

Antiviral drugs see demand surge in India, but segment declines 5.5%

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April

Indian drug makers gear up to make Gilead's remdesivir for Covid-19 therapy

Domestic players will be free to price it; Dutch firm Mylan also to make the drug in India; no royalty for Gilead as yet

Gilead enters licensing pact with 5 drug firms in India, Pak for remdesivir

According to the agreement the companies Cipla, Hetero Labs, Jubilant Life Sciences, Mylan, and Pakistan based Ferozsons Labs, to manufacture and sell remdesivir in 127 countries

Centre keen on testing Gilead's remdesivir to combat coronavirus

The USFDA has recently given an emergency approval to the drug for use on coronavirus patients

Hetero Group acquires Spain's Tarbis Farma for an undisclosed sum

Founded 25 years ago, the privately held Hetero Group is claimed to the the world's largest producer of anti-retroviral drugs